KO Validated
HIF1AN
Reaktivität: Human
WB
Wirt: Kaninchen
Monoclonal
unconjugated
Applikationshinweise
Immunohistochemistry (1:100) Western Blot (1:1000-1:5000) The optimal working dilution should be determined by the end user.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Buffer
In Tris-citrate/phosphate buffer, pH 7.0-8.0 (0.09 % sodium azide)
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
4 °C
Informationen zur Lagerung
Store at 4°C. Do not freeze.
Zheng, Linke, Dias, Zheng, Gradin, Wallis, Hamilton, Gustafsson, Ruas, Wilkins, Bilton, Brismar, Whitelaw, Pereira, Gorman, Ericson, Peet, Lendahl, Poellinger: "Interaction with factor inhibiting HIF-1 defines an additional mode of cross-coupling between the Notch and hypoxia signaling pathways." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 105, Issue 9, pp. 3368-73, (2008) (PubMed).
Birle, Hedley: "Suppression of the hypoxia-inducible factor-1 response in cervical carcinoma xenografts by proteasome inhibitors." in: Cancer research, Vol. 67, Issue 4, pp. 1735-43, (2007) (PubMed).
Li, Wang, Dutta, Lau, Jiang, Datta, Mukhopadhyay: "Protein kinase C-mediated modulation of FIH-1 expression by the homeodomain protein CDP/Cut/Cux." in: Molecular and cellular biology, Vol. 27, Issue 20, pp. 7345-53, (2007) (PubMed).
Ferguson, Muir: "MMP-2 and MMP-9 increase the neurite-promoting potential of schwann cell basal laminae and are upregulated in degenerated nerve." in: Molecular and cellular neurosciences, Vol. 16, Issue 2, pp. 157-67, (2000) (PubMed).